DDB2 Antibody - Cat. #: CSB-PA846067LA01HU

SKU: CSB-PA846067LA01HU

Size :50ug

Clone Number:

Aliases:damage-specific DNA binding protein 2 antibody; Damage-specific DNA-binding protein 2 antibody; DDB p48 subunit antibody; Ddb2 antibody; DDB2_HUMAN antibody; DDBb antibody; DNA damage-binding protein 2 antibody; UV-damaged DNA-binding protein 2 antibody; UV-DDB 2 antibody; Xeroderma pigmentosum group E protei antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:Q92466

Immunogen:Recombinant Human DNA damage-binding protein 2 protein (1-185AA)

Raised in:Rabbit

Species Reactivity:Human, Rat, Mouse

Tested Applications:ELISA, WB; Recommended dilution: WB:1:500-1:5000

Background:Required for DNA repair. Binds to DDB1 to form the UV-damaged DNA-binding protein complex (the UV-DDB complex). The UV-DDB complex may recognize UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair. The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches. Also appears to function as the substrate recognition module for the DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex DDB1-CUL4-ROC1 (also known as CUL4-DDB-ROC1 and CUL4-DDB-RBX1). The DDB1-CUL4-ROC1 complex may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage. The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair. The DDB1-CUL4-ROC1 complex also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER. Isoform D1 and isoform D2 inhibit UV-damaged DNA repair.

Clonality:Polyclonal

Isotype:IgG

Purification Method:>95%, Protein G purified

Conjugate:Non-conjugated

Buffer:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:DDB2

Research Areas:Epigenetics and Nuclear Signaling; Cancer